PGP and melanoma: Therefore, we tested elacridar, an inhibitor of P-gp and BCRP, but it had no impact on response to PD0332991 in the cell lines tested, suggesting that P-gp and BCRP do not play a role in resistance to PD0332991 in the melanoma cell lines.